Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83

1.

Statin use and nonalcoholic steatohepatitis in at risk individuals.

Dongiovanni P, Petta S, Mannisto V, Margherita Mancina R, Pipitone R, Karja V, Maggioni M, Kakela P, Wiklund O, Mozzi E, Grimaudo S, Kaminska D, Rametta R, Craxi A, Fargion S, Nobili V, Romeo S, Pihlajamaki J, Valenti L.

J Hepatol. 2015 May 13. pii: S0168-8278(15)00328-1. doi: 10.1016/j.jhep.2015.05.006. [Epub ahead of print]

PMID:
25980762
2.

Synthesis and antiproliferative activity of 3-(2-chloroethyl)-5-methyl-6-phenyl-8-(trifluoromethyl)-5,6-dihydropyrazolo[3,4-f][1,2,3,5]tetrazepin-4-(3H)-one.

Maggio B, Raimondi MV, Raffa D, Plescia F, Cascioferro S, Cancemi G, Tolomeo M, Grimaudo S, Daidone G.

Eur J Med Chem. 2015 May 26;96:98-104. doi: 10.1016/j.ejmech.2015.04.004. Epub 2015 Apr 6.

PMID:
25874335
3.

PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C.

Petta S, Vanni E, Bugianesi E, Rosso C, Cabibi D, Cammà C, Di Marco V, Eslam M, Grimaudo S, Macaluso FS, McLeod D, Pipitone RM, Abate ML, Smedile A, George J, Craxì A.

Aliment Pharmacol Ther. 2015 May;41(10):939-48. doi: 10.1111/apt.13169. Epub 2015 Mar 20.

PMID:
25801076
4.

Lupus in Latin-American patients: lessons from the GLADEL cohort.

Pons-Estel GJ, Catoggio LJ, Cardiel MH, Bonfa E, Caeiro F, Sato E, Massardo L, Molina-Restrepo JF, Toledano MG, Barile-Fabris LA, Amigo MC, Acevedo-Vásquez EM, Abadi I, Wojdyla D, Alarcón-Riquelme ME, Alarcón GS, Pons-Estel BA; GLADEL.

Lupus. 2015 May;24(6):536-45. doi: 10.1177/0961203314567753. Epub 2015 Feb 18. Review.

PMID:
25697768
5.

The UCP2 -866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis.

Fares R, Petta S, Lombardi R, Grimaudo S, Dongiovanni P, Pipitone R, Rametta R, Fracanzani AL, Mozzi E, Craxì A, Fargion S, Sesti G, Valenti L.

Liver Int. 2015 May;35(5):1574-80. doi: 10.1111/liv.12707. Epub 2014 Nov 20.

PMID:
25351290
6.

The hepatic expression of vitamin D receptor is inversely associated with the severity of liver damage in genotype 1 chronic hepatitis C patients.

Petta S, Grimaudo S, Tripodo C, Cabibi D, Calvaruso M, Di Cristina A, Guarnotta C, Macaluso FS, Minissale MG, Marchesini G, Craxì A.

J Clin Endocrinol Metab. 2015 Jan;100(1):193-200. doi: 10.1210/jc.2014-2741.

PMID:
25268393
7.

Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease.

Dongiovanni P, Petta S, Maglio C, Fracanzani AL, Pipitone R, Mozzi E, Motta BM, Kaminska D, Rametta R, Grimaudo S, Pelusi S, Montalcini T, Alisi A, Maggioni M, Kärjä V, Borén J, Käkelä P, Di Marco V, Xing C, Nobili V, Dallapiccola B, Craxi A, Pihlajamäki J, Fargion S, Sjöström L, Carlsson LM, Romeo S, Valenti L.

Hepatology. 2015 Feb;61(2):506-14. doi: 10.1002/hep.27490.

PMID:
25251399
8.

Novel antiproliferative chimeric compounds with marked histone deacetylase inhibitory activity.

Giacomini E, Nebbioso A, Ciotta A, Ianni C, Falchi F, Roberti M, Tolomeo M, Grimaudo S, Cristina AD, Pipitone RM, Altucci L, Recanatini M.

ACS Med Chem Lett. 2014 Jul 8;5(9):973-8. doi: 10.1021/ml5000959. eCollection 2014 Sep 11.

PMID:
25221651
9.

Inhibition of activated STAT5 in Bcr/Abl expressing leukemia cells with new pimozide derivatives.

Rondanin R, Simoni D, Romagnoli R, Baruchello R, Marchetti P, Costantini C, Fochi S, Padroni G, Grimaudo S, Pipitone RM, Meli M, Tolomeo M.

Bioorg Med Chem Lett. 2014 Sep 15;24(18):4568-74. doi: 10.1016/j.bmcl.2014.07.069. Epub 2014 Aug 1.

PMID:
25131537
10.

Primary cardiac disease in systemic lupus erythematosus patients: protective and risk factors--data from a multi-ethnic Latin American cohort.

García MA, Alarcón GS, Boggio G, Hachuel L, Marcos AI, Marcos JC, Gentiletti S, Caeiro F, Sato EI, Borba EF, Brenol JC, Massardo L, Molina-Restrepo JF, Vásquez G, Guibert-Toledano M, Barile-Fabris L, Amigo MC, Huerta-Yáñez GF, Cucho-Venegas JM, Chacón-Diaz R, Pons-Estel BA; Grupo Latino Americano de Estudio del Lupus Eritematoso (GLADEL).

Rheumatology (Oxford). 2014 Aug;53(8):1431-8. doi: 10.1093/rheumatology/keu011. Epub 2014 Mar 14.

PMID:
24633413
11.

Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease.

Petta S, Miele L, Bugianesi E, Cammà C, Rosso C, Boccia S, Cabibi D, Di Marco V, Grimaudo S, Grieco A, Pipitone RM, Marchesini G, Craxì A.

PLoS One. 2014 Feb 3;9(2):e87523. doi: 10.1371/journal.pone.0087523. eCollection 2014. Erratum in: PLoS One. 2014;9(3):e92497.

12.

PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease.

Petta S, Valenti L, Marchesini G, Di Marco V, Licata A, Cammà C, Barcellona MR, Cabibi D, Donati B, Fracanzani A, Grimaudo S, Parrinello G, Pipitone RM, Torres D, Fargion S, Licata G, Craxì A.

PLoS One. 2013 Sep 17;8(9):e74089. doi: 10.1371/journal.pone.0074089. eCollection 2013.

13.

PTPN22 association in systemic lupus erythematosus (SLE) with respect to individual ancestry and clinical sub-phenotypes.

Namjou B, Kim-Howard X, Sun C, Adler A, Chung SA, Kaufman KM, Kelly JA, Glenn SB, Guthridge JM, Scofield RH, Kimberly RP, Brown EE, Alarcón GS, Edberg JC, Kim JH, Choi J, Ramsey-Goldman R, Petri MA, Reveille JD, Vilá LM, Boackle SA, Freedman BI, Tsao BP, Langefeld CD, Vyse TJ, Jacob CO, Pons-Estel B; Argentine Collaborative Group, Niewold TB, Moser Sivils KL, Merrill JT, Anaya JM, Gilkeson GS, Gaffney PM, Bae SC, Alarcón-Riquelme ME; BIOLUPUS and GENLES Networks, Harley JB, Criswell LA, James JA, Nath SK.

PLoS One. 2013 Aug 7;8(8):e69404. doi: 10.1371/journal.pone.0069404. eCollection 2013.

14.

Mestizos with systemic lupus erythematosus develop renal disease early while antimalarials retard its appearance: data from a Latin American cohort.

Pons-Estel GJ, Alarcón GS, Burgos PI, Hachuel L, Boggio G, Wojdyla D, Nieto R, Alvarellos A, Catoggio LJ, Guibert-Toledano M, Sarano J, Massardo L, Vásquez GM, Iglesias-Gamarra A, Lavras Costallat LT, Da Silva NA, Alfaro JL, Abadi I, Segami MI, Huerta G, Cardiel MH, Pons-Estel BA; Grupo Latino Americano de Estudio de Lupus (GLADEL).

Lupus. 2013 Aug;22(9):899-907. doi: 10.1177/0961203313496339. Epub 2013 Jul 15.

15.

Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients.

Petta S, Grimaudo S, Marco VD, Scazzone C, Macaluso FS, Cammà C, Cabibi D, Pipitone R, Craxì A.

J Viral Hepat. 2013 Jul;20(7):486-93. doi: 10.1111/jvh.12072. Epub 2013 Mar 25.

PMID:
23730842
16.

In vivo liver expression of TLR2, TLR3 and TLR7 in chronic hepatitis C.

Tarantino G, Di Cristina A, Pipitone R, Almasio PL, Di Vita G, Craxi A, Grimaudo S.

J Biol Regul Homeost Agents. 2013 Jan-Mar;27(1):233-9.

PMID:
23489702
17.

MicroRNA-3148 modulates allelic expression of toll-like receptor 7 variant associated with systemic lupus erythematosus.

Deng Y, Zhao J, Sakurai D, Kaufman KM, Edberg JC, Kimberly RP, Kamen DL, Gilkeson GS, Jacob CO, Scofield RH, Langefeld CD, Kelly JA, Ramsey-Goldman R, Petri MA, Reveille JD, Vilá LM, Alarcón GS, Vyse TJ, Pons-Estel BA; Argentine Collaborative Group, Freedman BI, Gaffney PM, Sivils KM, James JA, Gregersen PK, Anaya JM, Niewold TB, Merrill JT, Criswell LA, Stevens AM, Boackle SA, Cantor RM, Chen W, Grossman JM, Hahn BH, Harley JB, Alarcόn-Riquelme ME; BIOLUPUS and GENLES networks, Brown EE, Tsao BP.

PLoS Genet. 2013;9(2):e1003336. doi: 10.1371/journal.pgen.1003336. Epub 2013 Feb 28.

18.

A natural-like synthetic small molecule impairs bcr-abl signaling cascades and induces megakaryocyte differentiation in erythroleukemia cells.

Turroni S, Tolomeo M, Mamone G, Picariello G, Giacomini E, Brigidi P, Roberti M, Grimaudo S, Pipitone RM, Di Cristina A, Recanatini M.

PLoS One. 2013;8(2):e57650. doi: 10.1371/journal.pone.0057650. Epub 2013 Feb 27.

19.

The new iodoacetamidobenzofuran derivative TR120 decreases STAT5 expression and induces antitumor effects in imatinib-sensitive and imatinib-resistant BCR-ABL-expressing leukemia cells.

Grimaudo S, Meli M, Di Cristina A, Ferro A, Pipitone MR, Romagnoli R, Simoni D, Dieli F, Tolomeo M.

Anticancer Drugs. 2013 Apr;24(4):384-93. doi: 10.1097/CAD.0b013e32835e64a0.

PMID:
23370613
20.

Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease.

Hribal ML, Procopio T, Petta S, Sciacqua A, Grimaudo S, Pipitone RM, Perticone F, Sesti G.

J Clin Endocrinol Metab. 2013 Feb;98(2):E304-8. doi: 10.1210/jc.2012-3290. Epub 2013 Jan 11.

PMID:
23316084
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk